171 related articles for article (PubMed ID: 11443863)
1. A new animal model for Epstein-Barr virus pathogenesis.
Wang F
Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863
[No Abstract] [Full Text] [Related]
2. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
Orlova N; Wang F; Fogg MH
J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.
Orlova N; Fogg MH; Carville A; Wang F
Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064
[TBL] [Abstract][Full Text] [Related]
4. Non-human Primate Lymphocryptoviruses: Past, Present, and Future.
Mühe J; Wang F
Curr Top Microbiol Immunol; 2015; 391():385-405. PubMed ID: 26428382
[TBL] [Abstract][Full Text] [Related]
5. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.
Ohashi M; Fogg MH; Orlova N; Quink C; Wang F
PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447
[TBL] [Abstract][Full Text] [Related]
6. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge.
Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI
PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
Herrman M; Mühe J; Quink C; Wang F
J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
[TBL] [Abstract][Full Text] [Related]
8. An animal model for acute and persistent Epstein-Barr virus infection.
Moghaddam A; Rosenzweig M; Lee-Parritz D; Annis B; Johnson RP; Wang F
Science; 1997 Jun; 276(5321):2030-3. PubMed ID: 9197263
[TBL] [Abstract][Full Text] [Related]
9. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques.
Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F
J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.
Silveira EL; Fogg MH; Leskowitz RM; Ertl HC; Wiseman RW; O'Connor DH; Lieberman P; Wang F; Villinger F
J Virol; 2013 Dec; 87(24):13904-10. PubMed ID: 24089556
[TBL] [Abstract][Full Text] [Related]
11. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques.
Fogg MH; Garry D; Awad A; Wang F; Kaur A
J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707
[TBL] [Abstract][Full Text] [Related]
12. Simian homologues of Epstein-Barr virus.
Wang F; Rivailler P; Rao P; Cho Y
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):489-97. PubMed ID: 11313007
[TBL] [Abstract][Full Text] [Related]
13. Is Epstein-Barr virus a human oncogene or only an innocent bystander?
Smith RD
Hum Pathol; 1997 Dec; 28(12):1333-5. PubMed ID: 9416687
[No Abstract] [Full Text] [Related]
14. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
Fogg MH; Kaur A; Cho YG; Wang F
J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
[TBL] [Abstract][Full Text] [Related]
15. The role of Epstein-Barr virus in lymphoid malignancies.
Su IJ; Chen JY
Crit Rev Oncol Hematol; 1997 May; 26(1):25-41. PubMed ID: 9246539
[No Abstract] [Full Text] [Related]
16. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques.
Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC
J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300
[TBL] [Abstract][Full Text] [Related]
17. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections.
Rao P; Jiang H; Wang F
J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361
[TBL] [Abstract][Full Text] [Related]
18. Summary of roundtable discussion meeting: non-human primates to assess risk for EBV-related lymphomas in humans.
Kawabata T; Weaver J; Thomas D; Rowe M; Wang F; Kamperschroer C; Haggerty H
J Immunotoxicol; 2012; 9(1):121-7. PubMed ID: 22136193
[TBL] [Abstract][Full Text] [Related]
19. A new form of Epstein-Barr virus latency in vivo.
Miyashita E; Thorley-Lawson DA
Curr Top Microbiol Immunol; 1995; 194():135-44. PubMed ID: 7895488
[No Abstract] [Full Text] [Related]
20. Ly6C
LeBel M; Egarnes B; Brunet A; Lacerte P; Paré A; Lacroix S; Brown JP; Gosselin J
Eur J Immunol; 2018 Feb; 48(2):250-257. PubMed ID: 28980305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
